Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial

<p><strong>Background</strong> Chronic pelvic pain affects 2–24% of women worldwide and evidence for medical treatments is scarce. Gabapentin is effective in treating some chronic pain conditions. We aimed to measure the efficacy and safety of gabapentin in women with chronic pelvi...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Horne, A, Vincent, K, Hewitt, C, Middleton, L, Koscielniak, M, Szubert, W, Doust, A, Daniels, J, GaPP2 collaborative
स्वरूप: Journal article
भाषा:English
प्रकाशित: Elsevier 2020